Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (52)

2023

  1. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 4949-4963

2022

  1. Neurogenetic traits outline vulnerability to cortical disruption in Parkinson's disease

    NeuroImage: Clinical, Vol. 33

  2. Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

    Brain, Vol. 145, Núm. 6, pp. 2092-2107

2021

  1. Brain Activity and Functional Connectivity Patterns Associated With Fast and Slow Motor Sequence Learning in Late Middle Adulthood

    Frontiers in Aging Neuroscience, Vol. 13

  2. Imaging of Stroke in Rodents Using a Clinical Scanner and Inductively Coupled Specially Designed Receiver Coils

    Annals of Biomedical Engineering, Vol. 49, Núm. 2, pp. 746-756

  3. Neuroplasticity during the transition period: How the adolescent brain can recover from aphasia. A pilot study

    Brain and Development, Vol. 43, Núm. 4, pp. 556-562

  4. Oligodendrocytes, a New Player in the Etiology of Parkinson's Disease

    Movement Disorders

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 2, pp. 437-450

  3. An application of generalized matrix learning vector quantization in neuroimaging

    Computer Methods and Programs in Biomedicine, Vol. 197

  4. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  5. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  6. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  7. Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease

    Movement Disorders, Vol. 35, Núm. 2, pp. 316-325

  8. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

  9. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats

    Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431

  10. [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 11, pp. 2602-2612

2019

  1. Dynamic atlas-based segmentation and quantification of neuromelanin-rich brainstem structures in Parkinson disease

    IEEE Transactions on Medical Imaging, Vol. 38, Núm. 3, pp. 813-823

  2. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 10, pp. 2065-2076

  3. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188